Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
This Institute was originally established as "India Centre of JALMA" in 1966 and was managed by a Tokyo based voluntary organisation -JALMA (Japanese Leprosy Mission for Asia). It has been renamed as "National Jalma Institute of Leprosy and other Mycobacterial Diseases" in 2005 to reflect its broader research areas.
The Institute has completed 37 years of its existence under ICMR. The Institute has a major thrust on leprosy (40%), relevant areas of tuberculosis and other mycobacteriosis (40%), HIV (10%) and Filariasis etc (10%). During its existence as a research Institute under ICMR the scientists of the Institute have continued to contributed on almost all aspects of leprosy, several cutting edge areas of tuberculosis ( DNA fingerprinting methods, drug resistance etc), selected areas of HIV-AIDs and has now made forays in to related problems like filariasis.
The Institute has state of the art facilities like BSL-3 labs, DNA chip lab, Proteomics Lab, all well equipped laboratories, modern hospital and well set Field Programmes at Ghatampur as well as Agra. The Institute has established its leadership in all important aspects of leprosy and mycobacterial research. The Institute is participating in and co-coordinating several multi-centric studies on Leprosy and Tuberculosis.
The following are the thrust areas of NJILOMD
To develop and standardize techniques of investigation for diagnosis, treatment and assessment for better management of leprosy in close co-ordination with the National Leprosy Eradication Programme (NLEP) in further reducing the disease and preventing deformities.
Early diagnosis and development of tests for early and rapid diagnosis of TB, drug sensitivity testing and designing and evaluating tests for rapid screening of sensitivity profile of Mycobacterium tuberculosis.
To pursue the following activities:
Developing newer modified methods of early diagnosis, assessment of treatment and also investigating the disease at patient and community level in both TB and leprosy.
Improving the methods of treatment in both the diseases and participating in multi-centric trials and studies in both TB and leprosy.
Conducting epidemiological studies such as intervention studies, investigations related to transmission and factors leading to reactions and preventing nerve damage in leprosy. Participating in operational surveys for disease prevalence & drug resistance surveillance in TB.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi